Brief: Kiromic Biopharma Inc - On May 10, 2022, Board Of Kiromic Biopharma, Inc. Appointed Pietro Bersani To Role Of Chief Executive Officer
11/05/2022 11:58
May 11 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA INC - ON MAY 10, 2022, BOARD OF KIROMIC
BIOPHARMA, INC. APPOINTED PIETRO BERSANI TO ROLE OF CHIEF
EXECUTIVE OFFICER
Source text for Eikon: [https://bit.ly/3L3v7VS]
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site